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ABSTRACT 34 
Hyalinizing trabecular tumor (HTT) is a rare thyroid neoplasm of follicular cell origin characterized by 35 
a trabecular growth pattern and prominent intratrabecular and intertrabecular hyalinization. These 36 
peculiar histological features allow the prompt recognition of this neoplasm in surgical specimens. 37 
However, cytological diagnosis of HTT remains elusive and misleading because of overlapping 38 
characteristics with other thyroid tumors, particularly papillary thyroid carcinoma (PTC), medullary 39 
thyroid carcinoma (MTC) and the newly described noninvasive follicular thyroid neoplasm with 40 
papillary-like nuclear features (NIFTP). Nevertheless, the proper recognition of this neoplasm on 41 
preoperative cytological preparations is important to avoid unnecessary overtreatment of this 42 
indolent lesion.  43 
A thorough review of the literature has revealed that the correct diagnosis of HTT in cytological 44 
smears is achieved in only 8% of cases. In a further 6% of cases, diagnostic doubt has been indicated. 45 
60% of published cases of HTT have been misdiagnosed as suggestive, suspicious or positive for PTC. 46 
These findings underline the difficulties of a cytological-based diagnosis of such entity. 47 
In this article we review the cytomorphological features of HTT and their correlation to histological 48 
features, to provide the reader with the tools to improve diagnostic performance in the identification 49 
of HTT on pre-operative cytology.50 
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INTRODUCTION 51 
Hyalinizing trabecular tumor (HTT) is a distinct but rare thyroid neoplasm of follicular cell origin 52 
characterized by a trabecular growth pattern and prominent intratrabecular and intertrabecular 53 
hyalinization. It usually occurs between the fourth and seventh decade of life and shows a marked 54 
predilection for females.1 By and large, the clinical behavior of HTT is benign and should therefore be 55 
treated conservatively, although it is worth noting that rare cases of invasive hyalinizing trabecular 56 
carcinomas have been reported in earlier literature.2-4 57 
 Although the peculiar histological features of this neoplasm allow prompt recognition in 58 
surgical specimens, cytological diagnosis of HTT remains elusive and misleading because of 59 
overlapping characteristics with other malignant thyroid tumors, including papillary thyroid 60 
carcinoma (PTC) and medullary thyroid carcinoma (MTC). For this reason, HTT recognition in fine-61 
needle aspiration (FNA) preparations is important to avoid unnecessarily aggressive treatment of 62 
such a benign neoplasm.5 Furthermore, it is difficult to distinguish between HTT and the recently 63 
described “noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)” in 64 
cytological preparations, mainly due to the fact that the cytological diagnostic criteria for both 65 
entities have not been well established yet.6 7 66 
The purpose of our review is to highlight the cytological and immunocytochemical features of 67 
HTT to help the practitioner cytopathologist with the difficult diagnosis of HTT, which represents the 68 
starting point for a correct therapeutic approach.  69 
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HISTORICAL PERSPECTIVE 70 
The first two reports of HTT were described by Zipkin (1905) and Masson (1922), who reported cases 71 
of HTT that they interpreted as carcinomas.8 9 Later, in 1982, Ward and colleagues described a similar 72 
case under the moniker “hyaline cell tumor of the thyroid with massive accumulation of cytoplasmic 73 
microfilaments”.10 However, the concept of HTT as a benign lesion originates from Carney and 74 
coworkers who, in 1987, reported 11 cases of noninvasive and non-metastasizing encapsulated 75 
thyroid tumors showing peculiar histological features, such as polygonal and elongated cells with a 76 
trabecular pattern of growth, associated with hyaline amyloid-like substance. They defined such 77 
lesions as hyalinizing trabecular adenomas (HTAs).11  78 
Following Carney’s description, most authors used the term HTA to define this neoplasm, 79 
and it was also adopted by the second edition of the WHO handbook on classification of thyroid 80 
tumors, where it was included in the chapter “Other adenomas”, together with salivary gland-type 81 
adenomas and adenolipomas.12 Subsequently, since some authors described a few cases showing 82 
malignant behavior (including metastases, vascular invasion or invasive growth into thyroid 83 
parenchyma) and RET/PTC rearrangements, the term HTT was considered a better moniker than 84 
HTA, and the lesion was classified as such in the third edition of the WHO classification.1   85 
 86 
ULTRASONOGRAPHIC FEATURES 87 
In two out of three small published series investigating US features of HTT, authors found that none 88 
of the patients showed any findings indicative of malignancy;13 14 in the third one, only 29% of 89 
patients showed malignant US findings.15 Overall, authors described the vast majority of HTT as being 90 
solid tumors, hypoechogenic or markedly hypoechogenic.13-15 91 
  92 
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CYTOPATHOLOGIC FEATURES  93 
Goellner and Carney first reported the cytological characteristics of HTT, acknowledging that this 94 
lesion showed features suggestive of both PTC and MTC.16 Cytological smears generally show cells 95 
that may be isolated, arranged in cohesive (Figures 1A, B) or loosely cohesive groups (Figure 1C) or 96 
syncytial tissue fragments with a trabecular pattern (Figure 1D). At times, neoplastic cells appear to 97 
radiate from central cores of acellular hyaline material or form follicle-like structures around it. 98 
Neoplastic cells are polygonal to spindle-shaped, containing a pale to dense cytoplasm that is often 99 
difficult to visualize, and oval to elliptic nuclei containing evenly distributed chromatin and 100 
micronucleoli. Intranuclear pseudoinclusions and nuclear grooving (Figure 1B, D) are frequently 101 
observed. The yellow cytoplasmic bodies observed by histology may also be seen in cytological 102 
samples.17 The presence of nuclear grooving, intranuclear pseudoinclusions and psammoma bodies 103 
may easily result in the diagnosis of PTC; indeed, the vast majority of published FNA cases were 104 
diagnosed on preoperative cytology as suggestive, suspicious or positive for PTC.16 18-21 105 
The hyaline material may be misinterpreted as amyloid, therefore suggesting a diagnosis of 106 
MTC, or even overlooked as colloid and not taken into account at all for diagnostic purposes. 107 
However, MTC aspirates show loosely cohesive groups with a dispersed pattern without any specific 108 
architectural configuration or isolated cells, whose nuclei are eccentric, pleomorphic, containing “salt 109 
and pepper” chromatin and no nucleoli. Nuclear grooving and psammoma bodies are not observed in 110 
MTC. The strange combination of features of both PTC and MTC, as well as the fact that these 111 
features do not completely fit the criteria for either entity, is the most useful clue for recognizing HTT 112 
by cytology.16 Immunocytochemical staining can help in distinguishing these entities.  113 
The difficulty of a cytological diagnosis of HTT is underlined by the fact that 60% of published 114 
cases of HTT in which a cytological diagnosis was included were misdiagnosed as suggestive, 115 
suspicious or positive for PTC (Table 1): among them, 41% were diagnosed as positive for PTC; 48% as 116 
suspicious for PTC; 6% as suggestive of PTC; 2% as consistent with PTC; 2% was diagnosed as follicular 117 
variant (FV)-PTC and 1% as a “trabecular epithelial tumor in keeping with PTC”. Of the remaining 40% 118 
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of cases, 6% were reported as PTC versus HTT; 10% as follicular neoplasms (FN); 1% as MTC; 10% as 119 
atypia of undetermined significance (AUS); and, finally, only 8% of cases were correctly identified as 120 
HTT by FNA (Figure 2).16-33  121 
Although architectural features are diminished in cytologic samples, they are not absent, and 122 
must be taken into account and correctly interpreted when making a diagnosis. When considering 123 
the cytomorphologic features of HTT, the absence of papillary structures and denuded fibrovascular 124 
stalks and the presence of elongated epithelial cells associated with acellular hyaline stroma, are all 125 
significant clues. Moreover, cell blocks from residual material or needle rinse fluid can provide 126 
additional information and material for ancillary studies, i.e. immunocytochemistry. 127 
Futhermore, in challenging cases, cytomorphologic findings can be integrated with US features to 128 
better refine the cytologic diagnosis: in cases with discordant cytologic-ultrasonographic findings, a note 129 
can be added to the diagnosis suggesting that when benign US features are present, HTT must be 130 
considered in the differential diagnosis of samples suspicious for malignancy (PTC). 131 
 132 
HISTOPATHOLOGIC FEATURES  133 
Grossly, HTT is usually a single, solid, well-circumscribed or encapsulated lesion that presents a 134 
homogeneous and delicately lobulated yellow-tan cut surface, measuring 2.5 cm or less in diameter 135 
(Figure 3A).1 136 
Microscopically, the main distinctive features are a diffuse trabecular-alveolar growth 137 
pattern and a prominent hyalinized intratrabecular stroma that closely resembles amyloid although it 138 
is negative for amyloid stain (Figure 3B). Neoplastic cells are medium to large sized, polygonal or 139 
fusiform, with a finely granular amphophilic, acidophilic or clear cytoplasm and nuclei showing 140 
prominent grooves and intranuclear pseudoinclusions (Figure 3C). They are arranged in trabeculae 141 
supported by a delicate fibrovascular stroma.1 In some cases, the spindle cell component may be so 142 
important as to suggest MTC (Figure 3B, inset); however, immunostaining for calcitonin, CEA, and 143 
thyroglobulin helps in the differential diagnosis. The so-called “yellow bodies”, round paranuclear 144 
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cytoplasmic pseudoinclusions with a light yellow tinge, slightly refractile and surrounded by a clear 145 
halo, are a peculiar feature of this neoplasm.34 Colloid is scant or absent and 146 
calcifications/psammoma bodies may be observed.1 In places, cells may be arranged in compact 147 
clusters closely resembling the “Zellballen” of paraganglioma, hence the alternative name of 148 
paraganglioma-like adenoma sometimes encountered in the literature.35 The hyaline material is 149 
closely associated with the trabeculae of HTT, is PAS positive and appears to be directly produced by 150 
neoplastic cells. It must be distinguished from the perivascular stromal hyalinization that is 151 
characteristic of other thyroid tumors and which results from degenerative changes within the 152 
lesion.1 35  153 
Ultrastructurally, the main features of HTT are the accumulation of intermediate filaments in 154 
the cytoplasm of the tumor cells and the abundance of extracellular basal membrane material that 155 
suggest a deregulation of secretory patterns.36-38 The yellow cytoplasmic inclusion bodies observed 156 
on hematoxylin and eosin-stained sections using electron microscopy are giant secondary lysosomes 157 
of multivesicular body subtypes.34   158 
 159 
IMMUNOCYTOCHEMISTRY AND IMMUNOHISTOCHEMISTRY 160 
HTT shows a distinctive cell membrane and cytoplasmic positivity for Ki-67 (using clone MIB-1) when 161 
the reaction is performed at room temperature. The cross-reactivity of the monoclonal MIB-1 162 
antibody with an epitope expressed at the cell membrane level seems to represent the putative 163 
mechanism of such findings.39 Positive immunoreactivity with MIB-1 in cytoplasmic and membranous 164 
patterns has been described in cytological specimens as well, and it has been suggested as a useful 165 
test when applied to aspirates in which HTT is suspected, but whose cytological features do not 166 
permit a definitive diagnosis.40 41 Therefore, immunocytochemistry can support the cytopathologist in 167 
diagnosing HTT in suspicious cases (Figure 3D, E). Although most authors propose 168 
immunohistochemical staining for MIB-1 as a useful diagnostic tool, others have recommended that 169 
the results of this test need to be carefully interpreted, as its specificity is not proven.39 42-44 It is 170 
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worth noting that such a staining pattern is obtained only with the MIB-1 clone and not with other Ki-171 
67 clones, and only when the procedure is carried out at room temperature.39 If this peculiarity is not 172 
taken into account and staining with the MIB-1 clone is carried out at 37 °C, a low-grade nuclear 173 
positivity will ensue and will lead to the wrong diagnosis. 174 
In keeping with their presumed follicular cell origin, most tumor cells are positive for 175 
thyroglobulin, thyroid transcription factor (TTF)-1 and negative for calcitonin (Table 2).1 Studies have 176 
shown discrepant results of cytokeratin (CK) profiling, with variable degrees of positivity for CK 7, 8, 177 
18 and 19.45-47  178 
 The staining for galectin-3, a β-galactosidase-binding lecithin used to differentiate benign and 179 
malignant follicular tumors, has been reported to be strong in 40% and weak or negative in 60% of 180 
HTTs.48  181 
Neuroendocrine differentiation, demonstrated by positivity for neuroendocrine markers such 182 
as chromogranin A and neuron-specific enolase, has been reported and proposed to account for the 183 
resemblance of an HTT growth pattern to paraganglioma and MTC.36 49 50  184 
 185 
MOLECULAR BIOLOGY 186 
Original detection of RET/PTC1 rearrangements in a percentage of cases similar to that described in 187 
PTC seemed to support the relationship between HTT and PTC that had also been suggested by some 188 
authors on the basis of morphological and cytological features.51-53 189 
In the study by Papotti et al., 4 of the 14 (28.6%) HTT investigated, using reverse 190 
transcription-polymerase chain reaction (RT-PCR) and Southern blot analysis, harbored RET/PTC1 191 
rearrangements;51 with the same method, Cheung and colleagues detected such rearrangements in 5 192 
out of 8 (62.5%) HTTs.52 Salvatore et al. found RET/PTC1 rearrangements in 13 out of 28 (46.4%) 193 
cases, but did not show evidence for any RAS or BRAF mutations.53 Because of such findings, the 194 
authors proposed that HTT might represent the “hyalinizing trabecular” variant of PTC and the 195 
moniker “tumor” is preferred to the benign connotation of the term “adenoma”. More recent 196 
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evidence provided by comparisons of microRNA expression in the two tumors did not support the 197 
hypothesis that HTT represents a variant of PTC: the expression of five microRNAs known to be 198 
upregulated in PTC was retrospectively analyzed in HTT and found to be different.54 199 
To date, no Next-Generation Sequencing study is available for HTT, nor have molecular 200 
analyses been applied to cytological material yet. 201 
 202 
DIFFERENTIAL DIAGNOSIS  203 
A review of the literature shows that the correct preoperative cytological diagnosis of HTT has been 204 
achieved in only 8% of cases, and in another 6% a diagnostic doubt has been indicated, while in the 205 
majority of cases the cytological diagnosis of malignancy was not confirmed on the resected surgical 206 
specimens (Table 1). Although it is generally believed that HTT can be frequently misdiagnosed as 207 
either PTC or MTC (because of the prominent PTC-like nuclear features and the presence of amyloid-208 
like hyaline material, respectively), only 1% of HTT has been diagnosed as MTC by preoperative 209 
cytology, compared to 60% which were diagnosed as PTC. 210 
Another entity that may appear in the differential diagnosis of HTT is NIFTP: confusion may 211 
arise because both entities present overlapping nuclear features of PTC in FNA material and because 212 
criteria for unequivocally identifying these entities by cytology have not yet been defined. 213 
 Primary thyroid paraganglioma, although extremely rare, may enter into the differential 214 
diagnosis, as HTT may present compact clusters that can be misinterpreted as “Zellballen” typically 215 
observed in paraganglioma.  216 
 217 
  218 
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MANAGEMENT 219 
FNA is an essential procedure in the preoperative evaluation of thyroid nodules. Its main role is the 220 
triage of patients who actually require surgery, thus reducing the number of unnecessary 221 
thyroidectomies and possible complications thereof.55  222 
Although radiologic and US features are often not provided to cytopathologists, they must be 223 
searched for and taken into account to plan appropriate patient management in a multidisciplinary 224 
tumor board. Recent literature suggests that HTT should be included in the differential diagnosis of 225 
solid tumors with benign US features but cytology suggestive of PTC.13-15 226 
As a cytological diagnosis of PTC entails an aggressive surgical treatment including complete 227 
thyroidectomy associated or not with central neck dissection, the correct distinction between HTT 228 
and PTC by FNA is important to guide proper management of patients and to avoid overtreatment 229 
because HTT can be treated by a simple lobectomy.  230 
It is important to note that an accurate diagnosis of HTT (and of any other neoplastic lesion) 231 
by FNA crucially depends on the sample being representative and adequate in cellularity and 232 
appropriately processed and stained, in order to provide high-quality preparations for assessment. 233 
When these conditions are not met, repeat sampling with or without on-site assessment should be 234 
considered prior to surgical management. Intraoperative consultation after a suboptimal cytologic 235 
assessment is not the method of choice in patient management.  236 
However, frozen section evaluation may have a role in guiding the correct surgical decision 237 
intraoperatively when it is prompted by a result of FNA cytology suspicious for malignancy on a 238 
sample that is representative of the lesion and well processed:  providing a trabecular pattern is 239 
identified, an initial lobectomy may be performed and total thyroidectomy may be deferred, thus 240 
preventing patients who are diagnosed with HTT by a definitive histopathological report from 241 
undergoing unnecessary total thyroidectomy.56 242 
In conclusion, if a clinically indolent tumor is suspected on the basis of radiological and 243 
cytological findings, judicious use of an indeterminate category (e.g. “Follicular Neoplasm/Suspicious 244 
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for a Follicular Neoplasm”), that in The Bethesda System for Reporting Thyroid Cytopathology entails 245 
a diagnostic lobectomy, may be the most appropriate course of action. 246 
 247 
CONCLUSION 248 
The history of the rare hyalinizing trabecular tumor is interesting and is marked by significant 249 
controversies; to date, uncertainty still remains concerning its malignant potential and, therefore, 250 
the most appropriate moniker for it.  251 
Although the identification of HTT on resection specimens is more straightforward, its 252 
recognition by FNA is misleading. However, careful attention and a high index of suspicion may help 253 
cytopathologists in providing a correct diagnosis and thus appropriately guide the surgeon and 254 
clinician, as HTT is virtually always benign and should be treated by a simple lobectomy.  255 
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TAKE HOME MESSAGES 256 
• Cytologic samples of HTT show elongated cells that may be isolated, arranged in 257 
cohesive/loosely cohesive groups, or syncytial tissue fragments with a trabecular pattern; 258 
hyaline material may form central cores surrounded by neoplastic cells or may be observed in 259 
the background of the smear. 260 
• Although intranuclear pseudoinclusions and nuclear grooving are frequently observed, the 261 
absence of papillary structures and fibrovascular stalks associated with the presence of a hyaline 262 
substance is an important clue to HTT diagnosis. 263 
• HTT should be included in the differential diagnosis of thyroid neoplasms with discordant US–264 
cytology readings, with FNA suspicious for PTC after a US without findings suggestive of 265 
malignancy. 266 
• When HTT is suspected on cytologic samples, judicious use of an indeterminate category leading 267 
to diagnostic lobectomy may be the most appropriate course of action on the part of the 268 
cytopathologist. 269 
 270 
 271 
 272 
  273 
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FIGURE LEGENDS 283 
 284 
Figure 1 Cytomorphological features of HTT. Cytology findings show a cellular smear with cells 285 
forming follicle-like structures (A, PAP x40) or cohesive aggregates (B, PAP x200) with large fragments 286 
of eosinophilic, hyaline, amorphous matrix (C, PAP x100). Neoplastic cells demonstrate well-formed 287 
intranuclear pseudoinclusions (arrow) and cells organized in trabecular structures (D, PAP x200).  288 
 289 
Figure 2 Cytological diagnoses of HTT in published literature. Only 8% of cases reported in the 290 
literature have been correctly diagnosed as HTT by cytology. The great majority have been reported 291 
as suspicious for PTC and PTC. The PTC category comprises cases diagnosed as: PTC, consistent with 292 
PTC, suggestive of PTC.  293 
 294 
Figure 3 Histological features of HTT. Low-power magnification shows an encapsulated lesion (A, H&E 295 
scanned slide) with the typical trabecular architecture and intratrabecular hyalinization (B, H&E 296 
x100). Rare spindle cell variants of HTT exist, and may create diagnostic confusion with the spindle 297 
cell variant of MTC. (B, inset, H&E x200). High-power magnification demonstrates intranuclear 298 
pseudoinclusions (arrow) and nuclear grooving (arrowhead) (C, H&E x400). Immunohistochemical 299 
staining with Ki-67 antibody (Mib-1 clone) at room temperature results in the characteristic 300 
peripheral cytoplasmic and membranous staining (D, x200); when the reaction is performed at 37 °C, 301 
no membrane localization is observed (E, x200).  302 
 303 
 304 
 305 
306 
15 
 
REFERENCES 307 
1. Carney JA, Volante M, Papotti M, et al. Hyalinizing trabecular tumour. In: DeLellis R, Lloyd R, 308 
Heitz PU, et al, ed. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press, 309 
2004:104-5. 310 
2. Molberg K, Albores-Saavedra J. Hyalinizing trabecular carcinoma of the thyroid gland. Hum 311 
Pathol 1994;25:192-7. 312 
3. McCluggage WG, Sloan JM. Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 313 
1996;28:357-62. 314 
4. Gonzalez-Campora R, Fuentes-Vaamonde E, Hevia-Vázquez A, et al. Hyalinizing trabecular 315 
carcinoma of the thyroid gland: report of two cases of follicular cell thyroid carcinoma with 316 
hyalinizing trabecular pattern. Ultrastruct Pathol 1998;22:39-46. 317 
5. Bishop JA, Ali SZ. Hyalinizing trabecular adenoma of the thyroid gland. Diagn Cytopathol 318 
2011;39:306-10. 319 
6. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular 320 
variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent 321 
tumors. JAMA Oncol 2016;2:1023-9. 322 
7. Baloch ZW, Seethala RR, Faquin WC, et al. Noninvasive follicular thyroid neoplasm with 323 
papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and 324 
implications for thyroid cytopathology. Cancer Cytopathol 2016;124:616-20. 325 
8. Zipkin R. Hyalinänliche collagene Kugeln als Produkte epithelialer Zellen in malignen 326 
Strumen. Virchows Arch Path Anat Physiol 1895;182:374-406. 327 
9. Masson P. Polarité cellulaire et structure des tumeurs paradoxales. Bull de l'Assoc franc p 328 
l'étude du cancer 1922;11:345-55. 329 
10. Ward JV, Murray D, Horvath E. Hyaline cell tumor of the thyroid with massive accumulation 330 
of cytoplasmic microfilaments. Lab Invest 1982;46:48A. 331 
11. Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J 332 
Surg Pathol 1987;11:583-91. 333 
12. Hedinger Chr, Williams ED, Sobin LH. Histological typing of Thyroid Tumors. In: Hedinger Chr, 334 
ed. World Health Organization International Classification of Tumors. 2nd ed. Berlin: 335 
Springer-Verlag, 1988:7. 336 
13. Jang H, Park CK, Son EJ, et al. Hyalinizing trabecular tumor of the thyroid: diagnosis of a rare 337 
tumor using ultrasonography, cytology, and intraoperative frozen sections. Ultrasonography 338 
2016;35:131-9. 339 
14. Lee S, Han BK, Ko EY, et al. The ultrasonography features of hyalinizing trabecular tumor of 340 
the thyroid are more consistent with its benign behavior than cytology or frozen section 341 
readings. Thyroid 2011;21:253-9. 342 
15. Choi WJ, Baek JH, Ha EJ, et al. The ultrasonography features of hyalinizing trabecular tumor 343 
of the thyroid gland and the role of fine needle aspiration cytology and core needle biopsy in 344 
its diagnosis. Acta Radiol 2015;56:1113-8. 345 
16 
 
16. Goellner JR, Carney JA. Cytologic features of fine-needle aspirates of hyalinizing trabecular 346 
adenoma of the thyroid. Am J Clin Pathol 1989:91;115-9. 347 
17. Bakuła-Zalewska E, Cameron R, Gałcziński JP, et al. Hyaline matrix in hyalinizing trabecular 348 
tumor: Findings in fine-needle aspiration smears. Diagn Cytopathol 2015;43:710-3. 349 
18. Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: cytologic 350 
features in 29 cases. Am J Surg Pathol 2004;28:859-67. 351 
19. Howard BE, Gnagi SH, Ocal IT, et al. Hyalinizing trabecular tumor masquerading as papillary 352 
thyroid carcinoma on fine-needle aspiration. ORL J Otorhinolaryngol Relat Spec 2013;75:309-353 
13. 354 
20. You TK, Jang KY, Moon WS, et al. Fine-needle aspiration cytology of hyalinizing trabecular 355 
adenoma of the thyroid in a patient with Hashimoto's thyroiditis: a case report. Acta Cytol 356 
2012;56:448-52. 357 
21. Evenson A, Mowschenson P, Wang H, et al. Hyalinizing trabecular adenoma--an uncommon 358 
thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am J 359 
Surg 2007;193:707-12. 360 
22. Kaleem Z, Davila RM. Hyalinizing trabecular adenoma of the thyroid. A report of two cases 361 
with cytologic, histologic and immunohistochemical findings. Acta Cytol 1997;41:883-8. 362 
23. Akin MR, Nguyen GK. Fine-needle aspiration biopsy cytology of hyalinizing trabecular 363 
adenomas of the thyroid. Diagn Cytopathol 1999;20:90-4. 364 
24. Jayaram G. Fine needle aspiration cytology of hyalinizing trabecular adenoma of the thyroid. 365 
Acta Cytol 1999;43:978-80. 366 
25. Boccato P, Mannarà GM, La Rosa F, et al. Hyalinizing trabecular adenoma of the thyroid 367 
diagnosed by fine-needle aspiration biopsy. Ann Otol Rhinol Laryngol 2000;109:235-8. 368 
26. Kuma S, Hirokawa M, Miyauchi A,  et al. Cytologic features of hyalinizing trabecular adenoma 369 
of the thyroid. Acta Cytol 2003;47:399-404. 370 
27. Gupta S, Modi S, Gupta V, et al. Hyalinizing trabecular tumor of the thyroid gland. J Cytol 371 
2010;27:63-5. 372 
28. Agarwal S, Mathur SR, Ray R, et al. Cytopathological diagnosis of hyalinizing trabecular 373 
tumour, a rare thyroid neoplasm. Cytopathology 2010;21:133-4. 374 
29. Kim T, Oh YL, Kim KM, et al. Diagnostic dilemmas of hyalinizing trabecular tumours on fine 375 
needle aspiration cytology: a study of seven cases with BRAF mutation analysis. 376 
Cytopathology 2011;22:407-13. 377 
30. Smith NR, Bullock MJ, Hart RD, et al. Hyalinizing trabecular tumour: review and new insights 378 
into the molecular biology. J Otolaryngol Head Neck Surg 2012;41:30-4.  379 
31. Arena S, Latina A, Marturano I, et al. Cytological diagnosis difficulties in hyalinizing trabecular 380 
tumor of the thyroid. J Endocrinol Invest 2011;34:887-8. 381 
32. Akin MR, Nguyen GK. Fine-needle aspiration biopsy cytology of hyalinizing trabecular 382 
adenomas of the thyroid. Diagn Cytopathol 1999;20:90-4. 383 
17 
 
33. Strong CJ, Garcia BM. Fine needle aspiration cytologic characteristics of hyalinizing trabecular 384 
adenoma of the thyroid. Acta Cytol 1990;34:359-362. 385 
34. Rothenberg HJ, Goellner JR, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: 386 
recognition and characterization of its cytoplasmic yellow body. Am J Surg Pathol 387 
1999;23:118-25. 388 
35. Nosé V, Volante M, Papotti M. Hyalinizing trabecular tumor of the thyroid: an update. Endocr 389 
Pathol 2008;19:1-8. 390 
36. Sambade C, Sarabando F, Nesland JM, et al. Hyalinizing trabecular adenoma of the thyroid 391 
(case of the Ullensvang course). Hyalinizing spindle cell tumor of the thyroid with dual 392 
differentiation (variant of the so-called hyalinizing trabecular adenoma). Ultrastruct Pathol 393 
1989;13:275-80. 394 
37. Li M, Carcangiu ML, Rosai J. Abnormal intracellular and extracellular distribution of basement 395 
membrane material in papillary carcinoma and hyalinizing trabecular tumors of the thyroid: 396 
implication for deregulation of secretory pathways. Hum Pathol 1997;28:1366-72. 397 
38. Katoh R, Kakudo K, Kawaoi A. Accumulated basement membrane material in hyalinizing 398 
trabecular tumors of the thyroid. Mod Pathol 1999;12:1057-61. 399 
39. Leonardo E, Volante M, Barbareschi M, et al. Cell membrane reactivity of MIB-1 antibody to 400 
Ki67 in human tumors: fact or artifact? Appl Immunohistochem Mol Morphol 2007;15:220-3. 401 
40. Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland 402 
identification through MIB-1 staining of fine-needle aspiration biopsy smears. Am J Clin 403 
Pathol 2004;122:506-10. 404 
41. Boerner SL, Asa SL. Hyalinizing trabecular tumor of the thyroid gland: much ado about 405 
nothing? Am J Clin Pathol 2004;122:495-6. 406 
42. Hirokawa M, Shimizu M, Manabe T, et al. Hyalinizing trabecular adenoma of the thyroid: its 407 
unusual cytoplasmic immunopositivity for MIB1. Pathol Int 1995;45:399-401. 408 
43. Hirokawa M, Carney JA, Ohtsuki Y. Hyalinizing trabecular adenoma and papillary carcinoma 409 
of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol 2000;24:877-81. 410 
44. Del Sordo R, Sidoni A. MIB-1 Cell membrane reactivity: a finding that should be interpreted 411 
carefully. Appl Immunohistochem Mol Morphol 2008;16:568. 412 
45. Fonseca E, Nesland JM, Sobrinho-Simoes M. Expression of stratified epithelial-type 413 
cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary 414 
carcinomas of the thyroid. Histopathology 1997;31:330-5. 415 
46. Papotti M, Riella P, Montemurro F, et al. Immunophenotypic heterogeneity of hyalinizing 416 
trabecular tumours of the thyroid. Histopathology 1997;31:525-33. 417 
47. Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing 418 
trabecular adenoma of the thyroid gland. Am J Surg Pathol 2000;24:575-8. 419 
48. Gaffney RL, Carney JA, Sebo TJ, et al. Galectin-3 expression in hyalinizing trabecular tumors of 420 
the thyroid gland. Am J Surg Pathol 2003;27:494-8. 421 
18 
 
49. Katoh R, Jasani B, Williams ED. Hyalinizing trabecular adenoma of the thyroid. A report of 422 
Three cases with immunohistochemical and ultrastructural studies. Histopathology 423 
1989;15:211-24. 424 
50. Shikama Y, Osawa T, Yagihashi N, et al. Neuroendocrine differentiation in hyalinizing 425 
trabecular tumor of the thyroid. Virchows Arch 2003;443:792-6. 426 
51. Papotti M, Volante M, Giuliano A, et al. RET/PTC activation in hyalinizing trabecular tumors of 427 
the thyroid. Am J Surg Pathol 2000;24:1615-21. 428 
52. Cheung CC, Boerner SL, MacMillan CM, et al. Hyalinizing trabecular tumor of the thyroid: a 429 
variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 2000;24:1622-430 
6. 431 
53. Salvatore G, Chiappetta G, Nikiforov YE, et al. Molecular profile of hyalinizing trabecular 432 
tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf 433 
and N-ras point mutations. Eur J Cancer 2005;41:816-21. 434 
54. Sheu SY, Vogel E, Worm K, et al. Hyalinizing trabecular tumour of the thyroid-differential 435 
expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 436 
2010;56:632-40. 437 
55. Tallini G, Gallo C. Fine-needle aspiration and intraoperative consultation in thyroid pathology: 438 
when and how? Int J Surg Pathol 2011;19:141-4. 439 
56. Sung SY, Shen HY, Hsieh B, et al. Hyalinizing trabecular tumor of thyroid: does frozen section 440 
prevent unnecessarily aggressive operation? Six new cases and a literature review. J Chin 441 
Med Assoc 2014;77:573-7. 442 
 443 
444 
19 
 
Table 1.  Summary of all reported cases of hyalinizing trabecular adenoma for which cytological 445 
diagnosis is available in the literature. 446 
Auth
or 
No
. 
of 
ca
se
s 
Sex Age Diameter Site Cytological diagnosis 
Thyroidectom
y 
M F 
M
ea
n 
Ra
ng
e 
M
ea
n 
Ra
ng
e 
Ri
g
ht 
lo
b
e 
L
e
f
t 
l
o
b
e 
Ot
he
r 
H
T
T 
H
T
T 
v
s 
P
T
C 
AUS/
FLUS 
FN/
SF
N 
Suspic
ious/ 
sugge
stive 
of PTC 
P
T
C 
N
D 
N
/
A 
M
T
C 
F
V
-
P
T
C 
Suspic
ious 
for 
malig
nancy 
Other 
H
e
m
i 
S
u
b
-
t
o
t
al 
To
tal 
Jang, 
2016
13 
12 1 11 55 
44
-
70 
1.
3 
0.
5-
4.
1 
N
/
A 
N
A  1 2 1 1 3 3 - 1 - - - - 6 2 4 
Baku
ła-
Zale
wska
, 
2015
17 
2 1 1 64 
63
-
65 
3.
0 
1.
0-
5.
0 
1 - 1 - - - 1 1 - - - - - - - 1 - 1 
Choi, 
2015
15 
19 
N
/
A 
N
/
A 
N/
A 
N/
A 
N/
A 
N/
A 
N
/
A 
N
/
A 
N/
A - - 6 - 9 2 1 - 1 - - - 
N
/
A 
N
/
A 
N/
A 
How
ard, 
2013
19 
1 - 1 57 - 6.0 - 1 - - - - - - - 1 - - - - - - 1 - - 
Smit
h, 
2012
30 
1 1 - 57 - 1.8 - 1 - - - - - - - - - - - 1 - - 
N
/
A 
N
/
A 
N/
A 
Kim, 
2011
29 
7 
N
/
A 
N
/
A 
N/
A 
N/
A 
N/
A 
N/
A 
N
/
A 
N
/
A 
N/
A - 2 - - 3 2 - - - - - - 2 - 5 
You, 
2012
20 
1 - 1 76 - 0.4 - 1 - - - - - - - 1 - - - - - - - - 1 
Aren
a, 
2011
31 
1 - 1 43 - 1.0 - - 1 - - - - - - - - - - - 1 - - - 1 
Lee, 
2011
14 
10 9 1 48 
26
-
81 
     - 2 - - 2 6 - - - - - - 3 - 7 
Agar
wal, 
2010
28 
1 1 - 25 - 2.0 - - - 1 1 - - - - - - - - - - - 
N
/
A 
N
/
A 
N/
A 
Gupt
a, 
2010
27 
1 1 - 28 - 3.1 - - 1 - - 1 - - - - - - - - - - 1 - - 
Even
son, 
2007
21 
7 2 5 60 
48
-
71 
1.
4 
1.
0-
2.
5 
   - - - - 6 1 - - - - - - 1 - 6 
Case
y, 
2004
40 
29          - - 2 - 12 11 - 4 - - - -    
Kum
a, 
2003
26 
16 2 14 48 
19
-
85 
4.
1 
2.
7-
7.
2 
1
0 6 -            - 
N
/
A 
N
/
A 
N/
A 
Bocc
ato, 
2000
25 
2 - 2 38.5 
34
-
43 
N/
A 
N/
A 1 1 - 1 - - - 1 - - - - - - - 
N
/
A 
N
/
A 
N/
A 
Jayar
am, 
1999
24 
1 1 - 47 - 4.5 - 1 - - - - - 1 - - - - - - - - 
N
/
A 
N
/
A 
N/
A 
20 
 
Akin, 
1999
32 
3 1 2 39.3 
34
-
45 
2.
5 
2.
0-
3.
0 
2 1 - 2 - - - 1 - - - - - - - 
N
/
A 
N
/
A 
N/
A 
Kale
em, 
1997
22 
2 - 2 42.5 
28
-
57 
2.
4 
0.
5-
6.
0 
1 1 - - - - 1 - 1 - - - - - - 1 - 1 
Stro
ng, 
1990
33 
1 - 1 53 - 2.0 - - 1 - - - - - - - - - - - - 
1 
(thyroi
ditis) 
1 - 1 
Goell
ner, 
1989
16 
5 1 4 44 
29
-
69 
N/
A 
N/
A 
N
/
A 
N
/
A 
N/
A - - - 1 3 1 - - - - - - 
N
/
A 
N
/
A 
N/
A 
M, male; F, female; HTT, hyalinizing trabecular tumor; PTC, papillary thyroid carcinoma; AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined 
significance; FN/SFN, follicular neoplasm, suspicious for follicular neoplasm; ND, non diagnostic;  MTC, medullary thyroid carcinoma; FV-PTC, follicular variant of 
papillary thyroid carcinoma; N/A, not available. 
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Table 2. Immunocytochemical staining in the differential diagnosis of hyalinizing trabecular tumor 448 
on FNA. 449 
 HTT PTC MTC 
Thyroglobulin + + - 
TTF-1 + + + 
Calcitonin - - + 
CEA - - + 
Chromogranin - - + 
Synaptophysin - - + 
Ki-67 (clone MIB-
1) 
+ (membranous) 100% expression 
at room temperature incubation; 
+ (nuclear) low expression at 37 °C 
incubation. 
+ (nuclear), usually 
low expression 
+ (nuclear), 
variable expression 
HTT, hyalinizing trabecular tumor; PTC, papillary thyroid carcinoma; MTC, medullary thyroid 
carcinoma. 
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 451 
 452 




